Schedule 13G ownership disclosure

Coherus Oncology Inc

Security class unavailable · CUSIP: 19249H103

Event date: 2017-07-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
5,554,147
Percent of class
10.8300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-17-000562
Form type
SC 13G
Filer
Coherus Oncology, Inc.
CIK
CIK 1512762
Filed
Aug 10, 2017
Reporting period
Jul 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub